Dr. Nabil Hanna, Ph.d.
Vice president
Pharmaceuticals
KAHR Medical Ltd
Israel
Biography
Dr. Hanna is the former Executive Vice President for Research at Biogen/Idec Inc. Dr. Hanna led the IDEC research team through the discovery and pre-clinical development of Rituximab and Zevalin, two drugs now approved for therapy of non-Hodgkin's lymphoma.
Research Interest
Immunology
